Trials / Recruiting
RecruitingNCT06625255
Promoting Playfulness
Promoting Playfulness: Tier 1 Strength-based Parent Education Program to Promote Child and Family Resilience
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Florida Gulf Coast University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Health inequalities, social isolation, and family adversity impact a child's development. Play is the context for child development in all areas. A parent's ability to support children at play while being playful contributes to their psychological adjustment. The proposed tier 1, strengths-based educational program for parents of children aged 2 to 5 years with and without disabilities combines elements of a play-based approach and tips on effective parenting to support children's development by equipping parents with knowledge and empowering them to become change agents in their children's lives.
Detailed description
Parents will be recruited through a convenience sampling method to either an intervention group delivered online or a control waitlist group. Parents will be asked to complete a set of questionnaires online to assess the proposed programs effectiveness. Data analysis will explore between and within group differences in parental sense of competency, parental stress, child's behavior, and ability to support child's play. Qualitative data will be collected through online open-ended questions and sessions' transcript which will be analyzed to identify benefits. The project will produce tangible outcomes that will contribute to fostering the resilience of families with young children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Parent Education - Promoting Playfulness | Parents will participate in 2, 45 minute parent education sessions promoting playfulness through information about child development, parent stressors, and parent advocacy. |
Timeline
- Start date
- 2024-09-16
- Primary completion
- 2026-10-01
- Completion
- 2026-10-01
- First posted
- 2024-10-03
- Last updated
- 2024-10-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06625255. Inclusion in this directory is not an endorsement.